Paxman AB

Equities

PAX

SE0009806284

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 06:59:47 2024-04-30 am EDT			5-day change	1st Jan Change
35.8 ^SEK	-4.53%		+3.77%	-2.72%

Jan. 15	Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Paxman AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021

May 26, 2021 at 06:00 am EDT

Paxman AB publ announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 22.906 million compared to SEK 25.899 million a year ago. Operating loss was SEK 2.350 million compared to SEK 1.779 million a year ago. Net loss was SEK 3.656 million compared to net income of SEK 2.568 million a year ago.

Latest news about Paxman AB

Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 14	CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
PAXMAN Announces Palmetto GBA Approves First Local Coverage Determination for Scalp Cooling Therapy	23-10-03	CI
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-24	CI
Paxman AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-24	CI
Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-24	CI
Paxman Scalp Cooling System Receives EU MDR Certification	23-01-26	CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-18	CI
Paxman AB Announces Its Selection by the SWOG Cancer Research Network for the Paxman Limb Cryocompression System to Be Used in A Prospectively Designed Study Looking At Prevention of Chemotherapy-Induced Peripheral Neuropathy	22-11-15	CI
Paxman AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-24	CI
Paxman AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-25	CI
Paxman Launches Enhanced Provider and Patient Assistance Services, as Well as Offering A New Business Model to Health Systems	22-05-09	CI
Paxman AB Signs Letter of Interest with Guangzhou Concord Medical Sci-Tech Innovation Center Co. Ltd. to Enter into Distribution and Marketing Agreement	22-04-12	CI
Paxman AB Signs New Distribution Agreement with Partner in Serbia	22-03-30	CI
Paxman AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021	22-02-25	CI
Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-19	CI
Paxman AB Announces Nelson Arcos S.A. as Their Global Distribution Partner for Paxman Equipment in Uruguay	21-11-11	CI
Paxman opens CIPN Clinical Trial with National University Hospital, Singapore	21-11-04	CI
Paxman AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-27	CI
Paxman AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-26	CI
Paxman Partners Paxman Coolers Ltd to Develop a Device	21-05-21	CI
Paxman AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-26	CI
Paxman AB Publ Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-20	CI
Paxman AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-27	CI

Chart Paxman AB

Duration

Period

More charts

Company Profile

Paxman AB (publ) is a Sweden-based developer of scalp cooling technology. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The Company offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Companyâs primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-22 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Paxman AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PAXMAN AB	-2.72%	65.24M
ABBOTT LABORATORIES	-3.43%	186B
MEDTRONIC PLC	-2.15%	107B
BECTON, DICKINSON AND COMPANY	-3.78%	67.44B
DEXCOM, INC.	+3.13%	50.03B
CENCORA, INC.	+16.34%	47.81B
HOYA CORPORATION	+4.79%	41.03B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.77%	26.85B
WEST PHARMACEUTICAL SERVICES, INC.	+3.15%	25.82B
ZIMMER BIOMET HOLDINGS, INC.	-0.43%	25.01B

Other Medical Equipment, Supplies & Distribution